PharmGen Science Inc (004720) — Strategic Asset Allocation Index
PharmGen Science Inc (004720) has a Strategic Asset Allocation Index of 19.4% as of June 2023. Strategic assets (PP&E of ₩42.69 Billion plus long-term investments of ₩-) total ₩42.69 Billion, measured against net assets of ₩220.19 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check PharmGen Science Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
PharmGen Science Inc Strategic Asset Allocation Index (2004–2021)
This chart shows how PharmGen Science Inc's Strategic Asset Allocation Index has evolved across 14 annual periods from 2004 to 2021. As of June 2023, the index stands at 19.4%, representing strategic assets of ₩42.69 Billion against net assets of ₩220.19 Billion KRW. See 004720 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for PharmGen Science Inc (2004–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for PharmGen Science Inc from 2004 to 2021, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 004720 market cap overview.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 27.5% | ₩34.90 Billion | ₩34.90 Billion | ₩- | ₩126.93 Billion | ▲ +6.9 pp |
| 2020 | 20.6% | ₩17.21 Billion | ₩17.21 Billion | ₩- | ₩83.57 Billion | ▼ -7.1 pp |
| 2019 | 27.7% | ₩15.60 Billion | ₩15.60 Billion | ₩- | ₩56.25 Billion | ▲ +6.2 pp |
| 2018 | 21.5% | ₩12.21 Billion | ₩8.62 Billion | ₩3.60 Billion | ₩56.85 Billion | ▼ -0.8 pp |
| 2017 | 22.3% | ₩11.38 Billion | ₩8.84 Billion | ₩2.54 Billion | ₩51.05 Billion | ▼ -4.3 pp |
| 2016 | 26.5% | ₩9.66 Billion | ₩8.35 Billion | ₩1.32 Billion | ₩36.41 Billion | ▲ +2.3 pp |
| 2015 | 24.2% | ₩6.95 Billion | ₩5.95 Billion | ₩997.34 Million | ₩28.66 Billion | ▼ -8.8 pp |
| 2014 | 33.0% | ₩6.64 Billion | ₩5.94 Billion | ₩703.54 Million | ₩20.12 Billion | ▲ +3.9 pp |
| 2013 | 29.1% | ₩6.94 Billion | ₩6.42 Billion | ₩526.33 Million | ₩23.83 Billion | ▲ +1.6 pp |
| 2012 | 27.5% | ₩7.12 Billion | ₩7.12 Billion | ₩- | ₩25.90 Billion | ▼ -11.7 pp |
| 2011 | 39.2% | ₩7.32 Billion | ₩7.32 Billion | ₩- | ₩18.69 Billion | ▲ +28.6 pp |
| 2005 | 10.6% | ₩3.50 Billion | ₩3.50 Billion | ₩- | ₩33.07 Billion | ▼ -1.8 pp |
| 2004 | 12.4% | ₩3.08 Billion | ₩3.08 Billion | ₩- | ₩24.91 Billion | ▲ +0.3 pp |
| 2004 | 12.0% | ₩3.10 Billion | ₩3.10 Billion | ₩- | ₩25.73 Billion | — |